Mustang Bio, Inc. (MBIO) is a publicly traded Healthcare sector company. As of August 5, 2026, MBIO trades at $0.60 with a market cap of $4.50M and a P/E ratio of -1.53. MBIO moved +0.00% today. Year to date, MBIO is -39.15%; over the trailing twelve months it is -61.98%. Its 52-week range spans $0.53 to $21.95. Rallies surfaces MBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.60 |
| Market Cap | $4.50M |
| P/E Ratio | -1.53 |
| EPS | $-0.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.95 |
| 52-Week Low | $0.53 |
| Volume | 6.68K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-1.92M |
| Gross Margin | 0.00% |
MBIO analyst coverage data. Average price target: $0.00.